Cancers 2010, 2(4), 2026-2043; doi:10.3390/cancers2042026
Review

Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors

Department of Microbiology and Immunology, Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan
Received: 18 October 2010; in revised form: 9 November 2010 / Accepted: 22 November 2010 / Published: 29 November 2010
(This article belongs to the Special Issue Pancreatic Cancer)
PDF Full-text Download PDF Full-Text [135 KB, uploaded 29 November 2010 14:23 CET]
Abstract: Pancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is curative by surgical resection, whilst standard chemotherapy for patients with advanced disease has only a modest effect with substantial toxicity. Clearly there is a need for the continual development of novel therapeutic agents to improve the current situation. Currently, there is a bulk of data indicating the important function of autophagy in cancer. While genetic evidence indicates that autophagy functions as a tumor suppressor, it is also apparent that autophagy can promote the survival of established tumors under stress conditions and in response to chemotherapy. This review provides a spectrum of potential pharmacological agents and autophagic approaches to enhance cell killing in pancreatic cancer.
Keywords: pancreatic cancer; autophagy; apoptosis; epigenetics; histone deacetylase; ER stress

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Rikiishi, H. Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors. Cancers 2010, 2, 2026-2043.

AMA Style

Rikiishi H. Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors. Cancers. 2010; 2(4):2026-2043.

Chicago/Turabian Style

Rikiishi, Hidemi. 2010. "Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors." Cancers 2, no. 4: 2026-2043.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert